Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents

被引：69
|
作者：
Doherty, AM [1 ]
机构：
[1] Inst Rech Jouveinal Parke Davis, F-94265 Fresnes, France
来源：
CURRENT OPINION IN CHEMICAL BIOLOGY | 1999年 / 3卷 / 04期
关键词：
D O I：
10.1016/S1367-5931(99)80068-4
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Preclinical and clinical studies of phosphodiesterase 4 inhibitors have shown that these agents may find utility in a wide range of inflammatory disorders, including asthma, chronic obstructive pulmonary disease, atopic dermatitis, rheumatoid arthritis, multiple sclerosis and various neurological disorders. The future of this class of drugs will depend upon the ability to demonstrate a reasonable safety margin against emesis and other typical phosphodieserase (PDE4) side effects, as well as in identification of the inflammatory disorder(s) most relevant to PDE4 inhibition.
引用
收藏
页码：466 / 473
页数：8
相关论文
共 50 条
  • [21] Natural Phosphodiesterase-4 Inhibitors with Potential Anti-Inflammatory Activities from Millettia dielsiana
    Le, Vu Thi Thu
    Hung, Hoang Van
    Ha, Nguyen Xuan
    Le, Cao Hong
    Minh, Pham Thi Hong
    Lam, Do Tien
    MOLECULES, 2023, 28 (21):
  • [22] Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis
    Hanifin, JM
    Chan, SC
    Cheng, JB
    Tofte, SJ
    Henderson, WR
    Kirby, DS
    Weiner, ES
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (01) : 51 - 56
  • [23] SURVEY OF ANTI-INFLAMMATORY AGENTS AS INHIBITORS OF OVULATION IN RABBITS
    ESPEY, LL
    DUMITRESCU, J
    FEDERATION PROCEEDINGS, 1980, 39 (03) : 822 - 822
  • [24] ANTI-INFLAMMATORY AGENTS AS INHIBITORS OF PROSTAGLANDIN SYNTHESIS IN MAN
    METZ, SA
    MEDICAL CLINICS OF NORTH AMERICA, 1981, 65 (04) : 713 - 757
  • [25] Recent development of lipoxygenase inhibitors as anti-inflammatory agents
    Hu, Chaoyu
    Ma, Shutao
    MEDCHEMCOMM, 2018, 9 (02) : 212 - 225
  • [26] Nasal testing for novel anti-inflammatory agents
    Erin, EM
    Neighbour, H
    Tan, AJ
    Kon, OM
    Durham, SR
    Hansel, TT
    CLINICAL AND EXPERIMENTAL ALLERGY, 2005, 35 (08): : 981 - 985
  • [27] Development of triarylsulfonamides as novel anti-inflammatory agents
    Greig, Iain R.
    Coste, Emmanuel
    Ralston, Stuart H.
    van 't Hof, Robert J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (03) : 816 - 820
  • [28] The Anti-Inflammatory Effect of Novel Antidiabetic Agents
    Theofilis, Panagiotis
    Sagris, Marios
    Oikonomou, Evangelos
    Antonopoulos, Alexios S.
    Siasos, Gerasimos
    Tsioufis, Kostas
    Tousoulis, Dimitris
    LIFE-BASEL, 2022, 12 (11):
  • [29] MEDI 352-Discovery of novel FMS kinase inhibitors as anti-inflammatory agents
    Meegalla, Sanath K.
    Illig, Carl R.
    Chen, Jinsheng
    Wall, Mark J.
    Wilson, Kenneth J.
    Ballentine, Shelley K.
    Rudolph, M. Jonathan
    DesJarlais, Renee L.
    Chan, Yanmin
    Schubert, Carsten
    Petrounia, Ioanna
    Crysler, Carl S.
    Molloy, Christopher J.
    Chaikin, Margery A.
    Manthey, Carl L.
    Player, Mark R.
    Tomczuk, Bruce E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [30] Novel NADPH Oxidase-2 Inhibitors as Potential Anti-Inflammatory and Neuroprotective Agents
    Juric, Matea
    Rawat, Varun
    Amaradhi, Radhika
    Zielonka, Jacek
    Ganesh, Thota
    ANTIOXIDANTS, 2023, 12 (09)
12345